Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
4.000
+0.130 (3.36%)
Dec 20, 2024, 4:00 PM EST - Market closed
Kyverna Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for KYTX stock have an average target of 23.2, with a low estimate of 6.00 and a high estimate of 40. The average target predicts an increase of 480.00% from the current stock price of 4.00.
Analyst Consensus: Buy
* Price targets were last updated on Nov 20, 2024.
Analyst Ratings
The average analyst rating for KYTX stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +50.00% | Nov 20, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $44 → $24 | Buy | Maintains | $44 → $24 | +500.00% | Nov 15, 2024 |
| UBS | UBS | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +225.00% | Oct 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $7 | Hold | Reiterates | $7 | +75.00% | Sep 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +75.00% | Aug 15, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.32
from -89.61
EPS Next Year
-3.78
from -3.32
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | |||
| Avg | n/a | n/a | n/a | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -3.21 | -3.14 | -1.63 | |||
| Avg | -3.32 | -3.78 | -3.60 | |||
| Low | -3.30 | -4.26 | -4.64 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.